All Comments by

  1. Paul Coleman on Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations.
  2. Nikolaos K. Robakis on An immunohistochemical study of centenarian brains: a comparison.
  3. Benjamin Wolozin on Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain.
  4. Carl Cotman on Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions.
  5. John Olney on Decreased expression of N-methyl-D-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain.
  6. Inez Vincent on Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
  7. Hiroshi Mori on Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease.
  8. Benjamin Wolozin on alpha-Synuclein membrane interactions and lipid specificity.
  9. Nikolaos K. Robakis on New susceptibility gene for Alzheimer's disease on chromosome 12?
  10. Paul Coleman on Striation is the characteristic neuritic abnormality in Alzheimer disease.
  11. Hiroshi Mori on Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments.
  12. John Olney on Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron.
  13. Hiroshi Mori on A new paradigm for neurotoxicity by FAD mutants of betaAPP: a signaling abnormality.
  14. Carl Cotman on Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3.
  15. Hiroshi Mori on Complement C1-inhibitor expression in Alzheimer's disease.